Gozco Plantations Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gozco Plantations Tbk. trades at Rp190 (market cap 1.15T, 16.26M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gozco Plantations Tbk. is far larger — about 11× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GZCO | SCPI | |
|---|---|---|
Market Cap | 1.15T | 104.4B |
Volume | 16.26M | — |
Lot | 162.63K | — |
Turnover | 3.08B | — |
Average Price | 189.63 | — |
Value | 3.08B | — |
Indicative Equilibrium Price | 190 | — |
Indicative Equilibrium Volume | 7.35K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Gozco Plantation (the company) was established under its original name of PT Surya Gemilang Sentosa base on notarial deed No.28 of Wachid Hasyim, S.H, dated on Aug 10, 2001.The Company’s articles of association has been amended several times, most recently by notarial deed No.192 of Irawan Soerodjo, S.H., dated Jan 31, 2008, concerning public offering.
Read more on GZCO →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →